Compare Quest Diagnostics Inc (DGX) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Kinross Gold Corporation — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Kinross Gold Corporation trades at $23.74 (market cap $27.62B). The key difference: Quest Diagnostics Inc and Kinross Gold Corporation are close in size by market cap, and Quest Diagnostics Inc pays the higher dividend (1.49%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Kinross Gold Corporation for 53 Days on average.
| DGX | KGC | |
|---|---|---|
Market Cap | $25.48B | $27.62B |
Volume | 941,866 | 6,347,266 |
Sector | Health | Basic Materials |
52-Week High | $247.45 | $38.06 |
52-Week Low | $173.49 | $22.47 |
Typical Hold Time | 56 Days | 53 Days |
Enterprise Value | $31.23B | $25.70B |
Dividend Yield | 1.49% | 0.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
KGC trades at $23.34, up 0.69% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company shows strong fundamentals, with Q2 2026 EPS beating estimates at $0.71 and robust cash flow growth, though recent news highlights production guidance cuts and legal investigations. Valuation ratios remain attractive, with a P/E of 8.87 and EV/EBITDA of 4.59.
The outlook is mixed: strong earnings and cash flow support upside to the $38.80 consensus price target, but risks include cost pressures, production setbacks, and legal scrutiny. Analyst sentiment is bullish with 59% buy ratings, but investors should weigh operational execution against macroeconomic gold price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
